Mechanisms of thrombosis in systemic lupus erythematosus.

MECHANISMS OF THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS. Roum Arch Microbiol Immunol. 2014 Jul-Dec;73(3-4):92-8 Authors: Metoni A, Mambet C, Necula LG, Aldea IM, Neagu AI, Matei L, Dragu D, Bleotu C, Ion DA, Diaconu CC Abstract Thrombotic events are highly prevalent in systemic lupus erythematosus (SLE). Antiphospholipid antibodies play an essential role in promoting thrombosis by activating several intracellular signaling pathways (TLR4, p38MAPK, NFkB) in platelets, monocytes and endothelial cells. New therapeutic opportunities might be offered by addressing these molecular targets. Chronic inflammatory status, the degree of disease activity and accelerated atherosclerosis are also responsible for the thrombotic phenotype in patients with SLE. The aim of this review is to highlight thrombosis mechanisms and to look for possible connection between SLE, antiphospholipid antibodies and cancer, especially myeloproliferative neoplasms. PMID: 26201124 [PubMed - indexed for MEDLINE]
Source: Roumanian Archives of Microbiology and Immunology - Category: Microbiology Tags: Roum Arch Microbiol Immunol Source Type: research